These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19754924)

  • 1. Associated cancers in parents and offspring of polycythaemia vera and myelofibrosis patients.
    Hemminki K; Sundquist J; Bermejo JL
    Br J Haematol; 2009 Nov; 147(4):526-30. PubMed ID: 19754924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial cancer risks in affected sibships: results from the Swedish family-cancer database.
    Hemminki K; Kyyrönen P
    Genet Epidemiol; 2000 Sep; 19(2):149-59. PubMed ID: 10962475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and familial risks in pituitary adenoma and associated tumors.
    Hemminki K; Försti A; Ji J
    Endocr Relat Cancer; 2007 Mar; 14(1):103-9. PubMed ID: 17395979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.
    Landgren O; Goldin LR; Kristinsson SY; Helgadottir EA; Samuelsson J; Björkholm M
    Blood; 2008 Sep; 112(6):2199-204. PubMed ID: 18451307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial association of inflammatory bowel diseases with other autoimmune and related diseases.
    Hemminki K; Li X; Sundquist K; Sundquist J
    Am J Gastroenterol; 2010 Jan; 105(1):139-47. PubMed ID: 19707191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial cancer in the family-cancer database.
    Hemminki K; Vaittinen P; Dong C
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):1005-10. PubMed ID: 10566556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden.
    Czene K; Hemminki K
    J Urol; 2003 Apr; 169(4):1271-5. PubMed ID: 12629341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial association of prostate cancer with other cancers in the Swedish Family-Cancer Database.
    Hemminki K; Chen B
    Prostate; 2005 Oct; 65(2):188-94. PubMed ID: 15948149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low incidence of familial occurrence of thrombocythaemia and/or thrombocytosis.
    Randi ML; Fabris F; Visentin I; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):695-9. PubMed ID: 2465250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial risks for eye melanoma and retinoblastoma: results from the Swedish Family-Cancer Database.
    Hemminki K; Chen B
    Melanoma Res; 2006 Apr; 16(2):191-5. PubMed ID: 16567975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of incident and fatal melanoma in individuals with a family history of incident or fatal melanoma or any cancer.
    Brandt A; Sundquist J; Hemminki K
    Br J Dermatol; 2011 Aug; 165(2):342-8. PubMed ID: 21457213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial risks for cancer as the basis for evidence-based clinical referral and counseling.
    Hemminki K; Sundquist J; Lorenzo Bermejo J
    Oncologist; 2008 Mar; 13(3):239-47. PubMed ID: 18378534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.
    Larsen TS; Hasselbalch HC; Pallisgaard N; Kerndrup GB
    Cancer Genet Cytogenet; 2007 Jan; 172(2):107-12. PubMed ID: 17213018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union.
    Moulard O; Mehta J; Fryzek J; Olivares R; Iqbal U; Mesa RA
    Eur J Haematol; 2014 Apr; 92(4):289-97. PubMed ID: 24372927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial myeloproliferative syndromes. Study of 6 families and review of literature].
    Kaufman S; Brière J; Bernard J
    Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):1-15. PubMed ID: 353725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway.
    Hemminki K; Tretli S; Sundquist J; Johannesen TB; Granström C
    Lancet Oncol; 2009 May; 10(5):481-8. PubMed ID: 19356978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions.
    Hemminki K; Li X; Sundquist J; Sundquist K
    Arthritis Rheum; 2009 Mar; 60(3):661-8. PubMed ID: 19248111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial aggregation of Hodgkin lymphoma and related tumors.
    Goldin LR; Pfeiffer RM; Gridley G; Gail MH; Li X; Mellemkjaer L; Olsen JH; Hemminki K; Linet MS
    Cancer; 2004 May; 100(9):1902-8. PubMed ID: 15112271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.